Cargando…
Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study
BACKGROUND: Little is known about prescription patterns of expensive non-recommended newer long-acting insulins (glargine 300 U/mL and degludec) for patients with type 2 diabetes mellitus (T2DM). AIM: To identify practice variation in, and practice- and patient-related characteristics associated wit...
Autores principales: | Dankers, Marloes, Hek, Karin, Nelissen-Vrancken, Marjorie, Houweling, Sebastiaan T, Mantel-Teeuwisse, Aukje, van Dijk, Liset |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172218/ https://www.ncbi.nlm.nih.gov/pubmed/35606162 http://dx.doi.org/10.3399/BJGP.2021.0581 |
Ejemplares similares
-
Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements
por: Dankers, Marloes, et al.
Publicado: (2023) -
Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences
por: Dankers, Marloes, et al.
Publicado: (2021) -
Non-adherence to guideline recommendations for insulins: a qualitative study amongst primary care practitioners
por: Dankers, M., et al.
Publicado: (2022) -
Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease
por: Dankers, Marloes, et al.
Publicado: (2020) -
National medicines policies – a review of the evolution and development processes
por: Hoebert, Joëlle M, et al.
Publicado: (2013)